Evaluation of simplified treat and extend regimen using ranibizumab in exudative age related macular degeneratio
Not Applicable
- Conditions
- Age related macular degeneration
- Registration Number
- JPRN-UMIN000014056
- Lead Sponsor
- Mie University Graduate School of Medicine Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) past intravitreal anti-VEGF therapy in the study eye 2) past intravitreal or subtenon injection of steroid therapy in the study eye 3) past vitrectomy therapy in the study eye 4) infection or suspicion of infection in eyes or periocular region 5) severe intraocular inflammation in eyes 6) past allergic reaction for ranibizumab 7) past allergic reaction for fluorescein, indocyanine green or iodine 8) pregnancy (positive pregnancy test) or lactating women 9) other conditions that the investigator believed would pose a significant hazard to the subject if investigational therapy were initiated.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of best corrected visual acuity and central retinal thickness (at 12th and 24th months).
- Secondary Outcome Measures
Name Time Method 1:A drop-out rate of the third month and the twelfth month 2:The study continuance rate until 24 months